The magic mushroom compound psilocybin shows long-lasting antidepressant effects in a clinical trial, with patients reporting ...

Major depressive disorder affects hundreds of millions worldwide, but a key to understanding its origins may lie in the brain ...

Since the COVID-19 pandemic, levels of clinically elevated depression and anxiety symptoms in children have skyrocketed ...

A new meta-analysis suggests that people with major depressive disorder have lower levels of the brain antioxidant ...

Studies have linked excessive screen time to mental health problems like depression in adolescents. | Neuroscience ...

Dark traits like narcissism and psychopathy are often associated with dysfunction, but new findings reveal that certain ...

A single dose of psilocybin coupled with “talk therapy” can significantly reduce depression in people with cancer for up to ...

New research shows a single dose leads to 'robust' reductions in depression and anxiety up to 2 years afterward.

Compass Pathways’ depression drug trial meets goals but falls short of investor hopes, triggering a sharp share selloff.

A first-of-its-kind clinical trial shows that ketamine treatment for severe, treatment-resistant depression is significantly ...

A new study from the American Cancer Society’s medical journal found that psilocybin — the active ingredient in “magic ...

The psilocybin found in "magic mushrooms" might be key to quelling depression among people battling cancer, a new study found ...